P. Jagtap
Oncology · 2001–2005
A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 5 citations into it
Whom P. Jagtap trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts P. Jagtap overall
Papers from P. Jagtap's perspective
Ordered by how strongly the researchers P. Jagtap trusts endorse each paper. Same corpus, a different order for every researcher.
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy (Nature)
- The PARP superfamily (Bioessays)
- The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors (Pharmacological Reviews)
- LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation (Journal of Cell Science)
- Regulation of an ATG7-beclin 1 Program of Autophagic Cell Death by Caspase-8 (Science)
- Autophagy as a cell death and tumor suppressor mechanism (Oncogene)
- Autophagy as a regulated pathway of cellular degradation. (Science)
- The role of autophagy during the early neonatal starvation period (Nature)
- Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage (Nature)
- Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor (Science)
Their papers
- Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury (2005) — 2,945 citations
- Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors (2005) — 909 citations
- Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation (2001) — 630 citations